POLE HOSPITALIER BIOLOGIE - medecine.univ-amu.fr · Pôle hospitalier. Biologie 2/21 Mise à jour : janvier 2015 Alain Nicolay (MCU-PH) Marguerite Gastaldi (MCU-PH) Catherine Defoort

Pôle hospitalier. Biologie 1/21

Mise à jour : janvier 2015

POLE HOSPITALIER BIOLOGIE

CHEF DE PÔLE : Professeur Bruno LACARELLE ADRESSE : Hôpital de la Timone - Service de Pharmacocinétique et Toxicologie

264 Rue Saint-Pierre 13385 MARSEILLE Cedex 5

TELEPHONE : 04.91.38.75.65

COURRIEL : [email protected]

RATTACHEMENTS : AP-HM

DISCIPLINES D’APPARTENANCES : Biochimie et Biologie Moléculaire, Hématologie, Immunologie, génétique, Biologie Cellulaire, Pharmacologie, Toxicologie, Oncologie

SPECIALITÉS : Biochimie et Biologie Moléculaire, Hématologie, Immunologie, Génétique, Biologie Cellulaire, Pharmacologie, Toxicologie, Oncologie

EFFECTIFS

Enseignants-Chercheurs (PU-PH, MCU-PH, CCA, AHU) : 32,79 ETP

Personnel Hospitalier (PH, Attaché) : 49,04 ETP (PC, Assistant) 2,80 ETP

Personnel Technique (Encadrement) : 14,00 ETP (Techniciens de Laboratoire) : 249,50 ETP

(Ingénieurs) : 31,90 ETP (Aide de Laboratoire – AEQ & Divers) : 36,80 ETP

Personnel Administratif : 44,70 ETP

Internes : 48,60 ETP Etudiants : 75,00 ETP

PERSONNELS RATTACHÉS A UNE EQUIPE DE RECHERCHE

INSERM UMR 911 CRO2 EQUIPE 4 L Ouafik (PU-PH)

INSERM UMR 911 CRO2 B Lacarelle (PU-PH) C Solas (MCU-PH)

Suzanne Monjanel (MCU-Attaché) J Ciccolini (MCU-Attaché)

UMR NORT inserm 1062, inra 1260

Marie-Christine Alessi (PU-PH) Pierre-Emmanuel Morange (PU-PH) Michel Fontes (PU-PH) Henri Portugal (PU-PH)

Marie-Françoise Aillaud (MCU-PH) Véronique Baccini (MCU-PH) Alain Margotat (MCU-PH) Richard Planells (MCU-PH)

mailto:[email protected]



Alain Nicolay (MCU-PH)

Marguerite Gastaldi (MCU-PH)

Catherine Defoort (MCU-PH) Alain Nicolay (MCU-PH) M Gastaldi (MCU-PH) A Margotat (MCU-PH) Charlotte Grosdidier (AHU)

Agathe Henneuse (AHU) UMR MD2 R Guieu (PU-PH)

PJ Lejeune (MCU-PH) G Mottola (MCU-PH) J Fromonot (AHU)

INSERM UMR_S910 Nicolas Lévy (PU-PH) Catherine Badens (PU-PH)

Christophe Beroud (PU-PH) Pierre Cau (PU-PH) Nicole Philip (PU-PH)

Martin Krahn (MCU-PH) Karine Nguyen (MCU-PH) Patrice Roll (MCU-PH) Andrée Robaglia-Schlupp (MCU-PH) Rafaelle Bernard (PH) Nathalie Bonello-Palot (PH)

Annachiara De Sandre-Giovanolli (PH) Sabine Sigaudy (PH) Elise Kaspi (AHU) Nathalie Banzet (Ingénieur AP-HM)

Inserm U1076 Nathalie Bardin (MCU-PH)

Inserm U1067/CNRS U7333 Pierre Bongrand (PU-PH) Philippe Robert (MCU-PH) Joanna Vitte (MCU-PH)

Cnrs U7286 José Boucraut (MCU-PH)

CNRS U 7259 Sophie Desplat-Jego (MCU-PH)

Inserm U1104/CNRS U7280 Eric Vivier (PU-PH) Frédéric Vely (MCU-PH)

CRN2M, UMR 7286 Alain Enjalbert (PU-PH) Anne Barlier (PU-PH)

Amapola Autillo-Touati (PU-PH) Jean-Louis Berge Lefranc (MCU-PH) A Saveanu (MCU-PH)

INSERM 1072 Jean Gabert (PU-PH) Annie Lévy-Mozziconnacci (MCU-PH)

UMR 1076 Françoise Dignat-George (PU-PH) Florence Sabatier (PU-PH)



Romaric Lacroix (MCU-PH)

Pascale Paul Sylvie Cointe

SERVICES HOSPITALIERS

INTITULÉ : Service de Transfert d’Oncologie Biologique RESPONSABLE : Pr L’Houcine OUAFIK DISCIPLINE : Oncologie Biologique

INTITULÉ : Département de Génétique Médicale RESPONSABLE : Pr Nicolas LEVY DISCIPLINE : Génétique

INTITULÉ : Service de Biologie Cellulaire RESPONSABLE : Dr Patrice ROLL DISCIPLINE : Biologie Cellulaire

INTITULÉ : Laboratoire d'Immunologie RESPONSABLE : Pr Pierre BONGRAND DISCIPLINE : Immunologie

INTITULÉ : Laboratoire de Biochimie

RESPONSABLE : Pr Henri PORTUGAL DISCIPLINE : Biochimie

INTITULÉ : Laboratoire de Biochimie et Biologie Moléculaire RESPONSABLE : Pr Régis GUIEU DISCIPLINE : Biochimie

INTITULÉ : Biochimie et Biologie Moléculaire. RESPONSABLE : Pr Jean GABERT DISCIPLINE : Biochimie et Biologie Moléculaire

INTITULÉ : laboratoire de Biologie Moléculaire, Hôpital de la Conception

RESPONSABLE : Pr Alain ENJALBERT DISCIPLINE : Biologie Moléculaire

INTITULÉ : Service d’Hématologie et de Biologie Vasculaire RESPONSABLE : Pr Françoise DIGNAT - GEORGE DISCIPLINE : Hématologie, Immunologie, Biologie Vasculaire

INTITULÉ : Pharmacocinétique et toxicologie RESPONSABLE : Pr Bruno LACARELLE DISCIPLINE : Pharmacocinétique, Toxicologie

INTITULÉ : Service d’Hématologie Hôpital Nord et Hôpital de la Timone RESPONSABLE : Pr Pierre-Emmanuel MORANGE DISCIPLINE : Hématologie

INTITULÉ : Service de Pharmacologie Clinique Hôpital de la Timone et Hôpitaux Sud RESPONSABLE : Pr Olivier BLIN DISCIPLINE : Pharmacologie

INTITULÉ : Service Pharmacologie Clinique CAP Hôpitaux Sud RESPONSABLE : Pr Nicolas SIMON DISCIPLINE : Pharmacologie



PUBLICATIONS ANNÉE 2013

1 Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, Kolyadko VN,

Chambost H, Mazurov AV, Ataullakhanov FI, Nurden AT, Alessi MC, Panteleev MA. Procoagulant platelets form anα-granule protein-covered 'cap' on their surface that promotes their attachment to aggregates. J Biol Chem. 2013;288:29621-32 (IF = 4.651)

2

Ambrosi P, Kreitmann B, Cohen W, Habib G, Morange P Anticoagulation with a new oral anticoagulant in heart transplant recipients.Int J Cardiol. 2013;168:4452-3 (IF = 6.175)

3 Amiot MJ, Romier B, Dao TM, Fanciullino R, Ciccolini J, Burcelin R, Pechere L, Emond C, Savouret

JF, Seree E. Optimization of trans-Resveratrol bioavailability for human therapy. Biochimie. 2013 Jun;95(6):1233-8.

4 André F, Ciccolini J, Spano JP, Penault-Llorca F, Mounier N, Freyer G, Blay JY, Milano G.

Personalized medicine in oncology: where have we come from and where are we going? Pharmacogenomics. 2013 Jun;14(8):931-9. doi: 10.2217/pgs.13.79.

5

Ayach L, Curti C, Montana M, Pisano P, Vanelle P. Actualités dans le traitement étiologique de la sclérose latérale amyotrophique. Amyotrophic lateral sclerosis: Update on etiological treatment Thérapie. Vol. 68, No. 2 (Mars-Avril 2013) : 93

6

Bakour S, Touati A, Sahli F, Ameur AA, Haouchine D, Rolain JM. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria. Diagn Microbiol Infect Dis. 2013 Aug;76(4):529-31.

7

Barbieri F, Albertelli M, Grillo F, Mohamed A, Saveanu A, Barlier A, Ferone D, Florio T. Neuroendocrine tumors: insights into innovative therapeutic options andrational development of targeted therapies. Drug Discov Today. 2013 Oct 27. piiS1359-6446(13)00382-6. doi: 10.1016/j.drudis.2013.10.015. [Epub ahead of print] PubMed PMID: 24171952.

8

Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Metronomics chemotherapy: time for computational decision support. Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52.

9 Barlesi F, Tomasini P, Fina F, Secq V, Greillier L, Nanni-Metellus I, Garcia S, Ouafik L. Regional molecular genetics centers in thoracic oncology: what and who should be tested?. Bull Cancer. 2013;100:737-41. Ait-Belkacem R, Calligaris D, Sellami L, Villard C, Granjeaud S, Schembri T, Berenguer C, Ouafik L, Figarella-Branger D, Chinot O, Lafitte D. Tubulin isoforms identified in the

brain by MALDI in-source decay. J Proteomics. 2013;79:172-9.

10 Baujat G, Huber C, El Hokayem J, Caumes R, Do Ngoc Thanh C, David A, Delezoide AL, Dieux- Coeslier A, Estournet B, Francannet C, Kayirangwa H, Lacaille F, Le Bourgeois M, Martinovic J, Salomon R, Sigaudy S, Malan V, Munnich A, Le Merrer M, Le Quan Sang KH, Cormier-Daire V.Asphyxiating thoracic dysplasia: clinical and molecular review of 39 families. J Med Genet. 2013

Feb;50(2):91-8

11

Baumstarck K, Bonello L, Dignat-George F, Sabatier F.Mobilization of CD34+KDR+ endothelial

progenitor cells predicts target lesion revascularization: a reply to a rebuttal concerning power and sample size calculation. J Thromb Haemost. 2013 Feb;11(2):398-9.

12

Ben Lassoued A1, Beaufils N, Dales JP, Gabert J. Hypoxia-inducible factor-1α as prognostic marker. Expert Opin Med Diagn. 2013 Jan;7(1):53-70.

http://www.ncbi.nlm.nih.gov/pubmed/23995838



















13 Berenguer-Daizé C, Boudouresque F, Bastide C, Tounsi A, Benyahia Z, Acunzo J, Dussault N,

Delfino C, Baeza N, Daniel L, Cayol M, Rossi D, El Battari A, Bertin D, Mabrouk K, Martin PM,

Ouafik L. Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice. Clin Cancer Res. 2013; 19(22):6138-50. Nouguerède E, Berenguer C,

Garcia S, Bennani B, Delfino C, Nanni I, Dahan L, Gasmi M, Seitz J-F, Martin P-M, Ouafik L. Expression of Adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenografts growth in vivo. Cancer Medicine. 2013; 2(2):196-207.

14

Bertin D, Grimaud JC, Lesavre N, Benelmouloud C, Desjeux A, Garcia S, et al. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease. PLoS One 2013;8:e80433.

15 Bertin D, Jourde-Chiche N, Bongrand P, Bardin N. Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol 2013;2013:182172.

16

Bertin D, Jourde-Chiche N, Bongrand P, Bardin N. Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol. 2013 ; 2013 :

182 172. doi: 10.1155/2013/182172. Epub 2013 Dec 18.

17 Bertin D, Stephan D, Khrestchatisky M, Desplat-Jégo S. Is TWEAK a Biomarker for

Autoimmune/Chronic Inflammatory Diseases? Front Immunol 2013;4:489.

18

Bessoles S, Angelov GS, Back J, Leclercq G, Vivier E, Held W. Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. J Immunol 2013;191:5044-51.

19

Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, et al. TRF2 inhibits a cell- extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol 2013;15:818-28.

20 Blons H, Rouleau E, Charrier N, Chatellier G, Côté JF, Pages JC, de Fraipont F, Boyer JC, Merlio JP, Morel A, Gorisse MC, de Cremoux P, Leroy K, Milano G, Ouafik L, Merlin JL, Le Corre D,

Aucouturier P, Sabourin JC, Nowak F, Frebourg T, Emile JF, Durand-Zaleski I, Laurent-Puig P; MOKAECM Collaborative Group. Performance and cost efficiency of KRAS mutation testing for

metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience. PLoS One. 2013;8(7):e68945.

21 Bonello L, Frère C, Paganelli F, Laine M. The impact of the environment on diseases and drugs. J Am Coll Cardiol. 2013 Aug 6;62(6):513-5.

22 Bonello L, Laine M, Baumstarck K, Fernandez J, Maillard L, Peyrol M, Bessereau J, Aradi D, Camilleri E, Roubille F, Piot C, Paganelli F, Camoin-Jau L, Dignat-George F. A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity. Int J Cardiol. 2013 Oct 9;168(4):4244-8.

23

Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, Gariboldi V, Condo J, Thuny F, Frere C, Camoin-Jau L, Paganelli F, Dignat-George F, Guieu R. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol. 2014 Mar 11;63(9):872-7. doi: 10.1016/j.jacc.2013.09.067. Epub 2013 Nov 27. PubMed PMID: 24291273.

24 Bonello L, Paganelli F, Laine M. Pharmacological interactions: the next frontier ? JACC Cardiovasc Interv. 2013 Feb;6(2):180-1.

25

Bordignon B, Chiron J, Fontés M. Ascorbic acid derivatives as a new class of antiproliferative molecules.Cancer Lett. 2013;338:317-27 (IF = 4.258)

26 Bordignon B, Mones S, Rahman F, Chiron J, Peiretti F, Vidal N, Fontes M. A derivative of ascorbic

acid modulates cAMP production. Biochem Biophys Res Commun. 2013;439:137-41 (IF = 2.406)

27

Boubred F, Saint-Faust M, Buffat C, Ligi I, Grandvuillemin I, Simeoni U. Developmental Origins of Chronic Renal Disease: An Integrative Hypothesis. Int J Nephrol. 2013;2013:346067. Epub 2013 Aug 29.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=24303014&_blank

























28 Bourgeois C, Douplat M, Guieu R, Pradel V, Fromonot J, Bonnet JL, Alazia M. [Interest of the

combination of high-sensitivity troponine and copeptin in diagnosis of non ST elevation myocardial

infarction]. Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):545-54.

29 Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE Group. Frequent large germline HRPT2deletions in a French National cohort of patients with primaryhyperparathyroidism. J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi:

10.1210/jc.2012-2789. Epub 2013 Jan 4. Erratum in: J Clin Endocrinol Metab. 2013 Apr;98(4):1766. PubMed PMID: 23293331.

30

Brodovitch A, Bongrand P, Pierres A. T lymphocytes sense antigens within seconds and make a decision within one minute. J Immunol 2013;191:2064-71.

31

Broucqsault N1, Morere J, Gaillard MC, Dumonceaux J, Torrents J, Salort-Campana E, Maues De Paula A, Bartoli M, Fernandez C, Chesnais AL, Ferreboeuf M, Sarda L, Dufour H, Desnuelle C, Attarian S, Levy N, Nguyen K, Magdinier F, Roche S.Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.Hum Mol

Genet. 2013 Oct 15;22(20):4206-14.

32 Busa T, Chabrol B, Perret O, Longy M, Philip N. Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling. Gene. 2013 Jan 10;512(2):194-7. doi:

10.1016/j.gene.2012.09.134. Epub 2012 Nov 2. PubMed PMID: 23124040.

33 Cacciagli P, Sutera-Sardo J, Borges-Correia A, Roux JC, Dorboz I, Desvignes JP, Badens C, Delepine M, Lathrop M, Cau P, Lévy N, Girard N, Sarda P, Boespflug-Tanguy O, Villard L.

Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. Am J Hum Genet. 2013 Sep 5;93(3):579- 86.

34

Calfee MW, Rose LJ, Morse S, Mattorano D, Clayton M, Touati A, Griffin-Gatchalian N, Slone C, McSweeney N. Comparative evaluation of vacuum-based surface sampling methods for collection of Bacillus spores. J Microbiol Methods. 2013 Dec;95(3):389-96.

35 Callier P, Aral B, Hanna N, Lambert S, Dindy H, Ragon C, Payet M, Collod-Beroud G, Carmignac V,

Delrue M, Goizet C, Philip N, Busa T, Dulac Y, Missotte I, Sznajer Y, Toutain A, Francannet C, Megarbane A, Julia S, Edouard T, Sarda P, Amiel J, Lyonnet S, Cormier-Daire V, Gilbert B, Jacquette A, Heron D, Collignon P, Lacombe D, Morice-Picard F, Jouk P, Cusin V, Willems M, Sarrazin E, Amarof K, Coubes C, Addor M, Journel H, Colin E, Khau Van Kien P, Baumann C, Leheup B, Martin-Coignard D, Doco-Fenzy M, Goldenberg A, Plessis G, Thevenon J, Pasquier L, Odent S, Vabres P, Huet F, Marle N, Mosca-Boidron A, Mugneret F, Gauthier S, Binquet C, Thauvin-Robinet C, Jondeau G, Boileau C, Faivre L. Systematic molecular and cytogenetic

screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet. 2013 Mar 18. doi: 10.1111/cge.12094. [Epub ahead of print] PubMed PMID: 23506379.

36

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. J Hepatol. 2014 Jan;60(1):46-53. doi:

10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

37

Cayla G, Cuisset T, Silvain J, O'Connor SA, Kerneis M, Castelli C, Quilici J, Bonnet JL, Alessi MC, Morange PE, Collet JP, Montalescot G. Prasugrel monitoring and bleeding in real world patients. Am J Cardiol. 2013;11138-44. (IF = 3.425)

38

Cayla G, Morange PE, Chambost H, Schved JF. Management of cardiovascular disease in haemophilia.Thromb Res. 2013;132:8-14 (IF = 2.372)

39

Chabbert-Buffet N, Guigues B, Trillot N, Biron C, Morange P, Pernod G, Scheffler M, Brugere S, Hedon B. [DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGM- GEHT-SFMV group].J Gynecol Obstet Biol Reprod (Paris). 2013;42:309-15 (IF = 0.448)













40 Chassaing N1, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, Boute- Benejean O, Dollfus H, Duban-Bedu B, Gilbert-Dussardier B, Giuliano F, Gonzales M, Holder-

Espinasse M, Isidor B, Jacquemont ML, Lacombe D, Martin-Coignard D, Mathieu-Dramard M, Odent S, Picone O, Pinson L, Quelin C, Sigaudy S, Toutain A, Thauvin-Robinet C, Kaplan J, Calvas P. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.Clin Genet. 2013 Sep 10.

41

Ciccolini J, Fanciullino R, Milano G. Predicting survival of gastric cancer patients treated with 5- fluorouracil-based regimen: falling again on TP53 Pharmacogenomics 07/2013; 14(10):1137- 1138.

42

Ciccolini J, Peters GJ, Giovannetti E. Gender, cytidine deaminase, and 5-aza/decitabine--letter. Clin Cancer Res. 2013 Jun 1;19(11):3105.

43

Colson P, Bregigeon S, Tourres C, Solas C, Poizot-Martin I, Tamalet C. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient. J Clin Virol. 2013 Sep;58(1):309-14.

44 Cordier C, Taris N, De Pauw A, Sobol H, Philip N, Voelckel MA. French professionals in genetic counselor careers. J Genet Couns. 2013 Dec;22(6):844-8. doi: 10.1007/s10897-013-9599-x.

Epub 2013 May 21. PubMed PMID: 23689926.

45 Cottereau E, Mortemousque I, Moizard MP, Bürglen L, Lacombe D, Gilbert-Dussardier B, Sigaudy S, Boute O, David A, Faivre L, Amiel J, Robertson R, Viana Ramos F, Bieth E, Odent S, Demeer B, Mathieu M, Gaillard D, Van Maldergem L, Baujat G, Maystadt I, Héron D, Verloes A, Philip N,

Cormier-Daire V, Frouté MF, Pinson L, Blanchet P, Sarda P, Willems M, Jacquinet A, Ratbi I, Van Den Ende J, Lackmy-Port Lis M, Goldenberg A, Bonneau D, Rossignol S, Toutain A..Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. Am J Med Genet C Semin Med Genet. 2013 May;163C(2):92-105

46

Courcet JB, Faivre L, Michot C, Burguet A, Perez-Martin S, Alix E, Amiel J, Baumann C, Cordier MP, Cormier-Daire V, Delrue MA, Gilbert-Dussardier B, Goldenberg A, Jacquemont ML, Jaquette A, Kayirangwa H, Lacombe D, Le Merrer M, Toutain A, Odent S, Moncla A, Pelet A, Philip N, Pinson L,

Poisson S, Kim-Han le QS, Roume J, Sanchez E, Willems M, Till M, Vincent-Delorme C, Mousson C, Vinault S, Binquet C, Huet F, Sarda P, Salomon R, Lyonnet S, Sanlaville D, Geneviève D. Clinical and molecular spectrum of renal malformations in Kabuki syndrome. J Pediatr. 2013 Sep;163(3):742-6. doi: 10.1016/j.jpeds.2013.02.032. Epub 2013 Mar 25. PubMed PMID:

23535010.

47 Cristofaro B, Shi Y, Faria M, Suchting S, Leroyer AS, Trindade A, Duarte A, Zovein AC, Iruela-

Arispe ML, Nih LR, Kubis N, Henrion D, Loufrani L, Todiras M, Schleifenbaum J, Gollasch M, Zhuang ZW, Simons M, Eichmann A, le Noble F. Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models. Development. 2013 Apr;140(8):1720-9.

48 Cuisset T, Grosdidier C, Loundou AD, Quilici J, Loosveld M, Camoin L, Pankert M, Beguin S, Lambert M, Morange PE, Bonnet JL, Alessi MC. Clinical Implications of Very Low On-Treatment platelet reactivity in patients treated with thienopyridine: The POBA study (Predictor of bleedings

with antiplatelet drugs).JACC Cardiovasc Interv. 2013;6:854-63 (IF = 6.552)

49

Cuisset T, Quilici J, Morange PE, Bonnet JL, Alessi MC. Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndrome.Int J Cardiol. 2013 ;168:1565-6. (IF = 6.175)

50

Cuisset T,Cayla G, Quilici J, Pankert M, Deharo P, Bonnet G, Grosdidier C, Beguin S, Morange P, Bonnet JL, Alessi MC.Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome. Int J Cardiol. 2013 ;168:2988-9 (IF = 6.175)

51

Cuny T, Barlier A. The significance of MEN1 mutations in pituitary carcinomas. Biomark Med. 2013 Aug;7(4):567-9. doi: 10.2217/bmm.13.69. PubMed PMID: 23905891.























52 Cuny T, Pertuit M, Sahnoun-Fathallah M, Daly A, Occhi G, Odou MF, Tabarin A, Nunes ML,

Delemer B, Rohmer V, Desailloud R, Kerlan V, Chabre O, Sadoul JL, Cogne M, Caron P, Cortet-

Rudelli C, Lienhardt A, Raingeard I, Guedj AM, Brue T, BeckersA, Weryha G, Enjalbert A, Barlier A. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't

forget MEN1 genetic analysis. Eur J Endocrinol. 2013 Mar 15;168(4):533-41. doi: 10.1530/EJE- 12-0763. Print 2013Apr. PubMed PMID: 23321498.

53

D. Barbolosi A. Benabdallah S. Benzekry J. Ciccolini C. Faivre F. Hubert F. Verga B. You A Mathematical Model for Growing Metastases on Oncologists’s Service. In book: Computational Surgery and Dual Training, Publisher: SPRINGER, Editors: Garbey, M, Bass, B.L., Collet, C, Mathelin, M, Tran-Son-Tay, R. Eds, pp.331-338

54

Daumas A, Eraud J, Hautier A, Sabatier F, Magalon G, Granel B.Interests and potentials of adipose tissue in scleroderma] Rev Med Interne. 2013 Dec;34(12):763-9

55

Daumas A, Grob A, Faucher B, Melenotte C, Rossi P, Jean E, et al. Une cause rare de cervicalgie au cours d'une sclérodermie systémique. Rev Med Interne 2013;34:719-20.

56

Daumas A, Mélenotte C, Jimenez S, Rossi P, Jean E, Figarella-Branger D, et al. Des douleurs des membres supérieurs après un effort intense. Rev Med Interne 2013.

57

Deharo JC, Guieu R, Mechulan A, Peyrouse E, Kipson N, Ruf J, Gerolami V, Devoto G, Marrè V, Brignole M. Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. J Am Coll Cardiol. 2013Sep 17;62(12):1075-80. doi: 10.1016/j.jacc.2013.05.060. Epub 2013 Jun 27. PubMed PMID: 23810895.

58 Deharo P, Bassez C, Bonnet G, Pankert M, Quilici J, Lambert M, Verdier V, Morange P, Alessi MC, Bonnet JL, Cuisset T. Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison. Int J Cardiol. 2013;170:e21-2. (IF = 6.175)

59

Deharo P, Pons C, Pankert M, Bonnet G, Quilici J, Grosdidier C, Beguin S, Morange P, Alessi MC, Bonnet JL, Cuisset T. Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: The POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.Int J Cardiol. 2013;168:5004-5 (IF = 6.175)

60 Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Phillips CM, Hall W, Gjelstad IM, Lairon D, Saris W, Kieć-Wilk B, Karlström B, Drevon CA, Defoort C, Blaak EE, Dembinska-Kieć A, Risérus U, Lovegrove JA, Roche HM, Lopez-Miranda J. A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.Nutr Metab Cardiovasc. Dis. 2013;23:417-23 (IF = 3.875)

61 Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, Higgins AM, Coleman

K, Chow C, Jalbrzikowski M, Bearden CE, Bailey A, Vangkilde A, Olsen L, Olesen C, Skovby F, Werge TM, Templin L, Busa T, Philip N, Swillen A, Vermeesch JR, Devriendt K, Schneider M, Dahoun S, Eliez S, Schoch K, Hooper SR, Shashi V, Samanich J, Marion R, van Amelsvoort T, Boot E, Klaassen P, Duijff SN, Vorstman J, Yuen T, Silversides C, Chow E, Bassett A, Frisch A, Weizman A, Gothelf D, Niarchou M, van den Bree M, Owen MJ, Suñer DH, Andreo JR, Armando M, Vicari S, Digilio MC, Auton A, Kates WR, Wang T, Shprintzen RJ, Emanuel BS, Morrow BE.

Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.

Am J Hum Genet. 2013 Mar 7;92(3):439-47. doi: 10.1016/j.ajhg.2013.01.018. Epub 2013 Feb 28. Erratum in: Am J Hum Genet. 2013 Apr 4;92(4):637. Jarlbrzkowski, Maria [corrected to Jalbrzikowski, Maria]. PubMed PMID: 23453669; PubMed Central PMCID: PMC3591861.

62

Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 Binding Protein. Front Immunol. 2013 Oct 8;4:289.

63

Djoudi F, Bonura C, Benallaoua S, Touati A, Touati D, Aleo A, Cala C, Fasciana T, Mammina C. Panton-Valentine leukocidin positive sequence type 80 methicillin-resistant Staphylococcus aureus carrying a staphylococcal cassette chromosome mec type IVc is dominant in neonates and

children in an Algiers hospital. New Microbiol. 2013 Jan;36(1):49-55.


















64 Dreux S, Nguyen C, Czerkiewicz I, Schmitz T, Azria E, Fouré MA, Muller F; ABA Study Group.

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide

study. Am J Obstet Gynecol. 2013 May;208(5):397.e1-5.

65

Dumètre A, Dubey JP, Ferguson DJ, Bongrand P, Azas N, Puech PH. Mechanics of the Toxoplasma gondii oocyst wall. Proc Natl Acad Sci U S A 2013;110:11535-40.

66

Dupont J, Fromonot J, Franceschi F, Deharo JC, Boucraut J, Quilici J, Bonnet JL, Monserrat C, Guieu R. A case of false positive troponin elevation: role of the biological laboratory. Int J Cardiol. 2013 4 :125-127

67

DYSCERNE expert panel. Dysmorphology at a distance: results of a web-based diagnostic service. Eur J Hum Genet. 2014 Mar;22(3):327-32. doi: 10.1038/ejhg.2013.137. Epub 2013 Jul 10. PubMed PMID: 23838594.

68

Evrard A, Lacarelle B, Ciccolini J. Severe or lethal toxicities with nucleosidic analogs: time for action. Pharmacogenomics. 2013 Feb;14(3):227-30. doi: 10.2217/pgs.12.208. No abstract available.

69 Fanciullino R, Ciccolini J, Milano G. Challenges, expectations and limits for nanoparticles-based

therapeutics in cancer: a focus on nano-albumin-bound drugs. Crit Rev Oncol Hematol. 2013

Dec;88(3):504-13. doi: 10.1016/j.critrevonc.2013.06.010. Epub 2013 Jul 18. Review.

70

Fanciullino R, Mollard S, Correard F, Giacometti S, Serdjebi C, Iliadis A, Ciccolini J. Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters. Pharm Res. 2014 Apr 22. [Epub ahead of print]

71

Fanciullino R, Mollard S, Giacometti S, Berda-Haddad Y, Chefrour M, Aubert C, Iliadis A, Ciccolini J. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity. Pharm Res. 2013 May;30(5):1281-90. doi: 10.1007/s11095-012-0967-2. Epub 2013 Feb 6.

72

Farnault L, Chambost H, Michel G, Thuret I, de Saint Basile G, Fischer A, et al. Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency. J Allergy Clin Immunol 2013;131:1230-3, 1233.e1-2.

73 Fernandez C, Bardin N, De Paula AM, Salort-Campana E, Benyamine A, Franques J, et al. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis. Medicine (Baltimore) 2013;92:15-24.

74

Figarella-Branger D, Raverot G; members of HYPOPRONOS, Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A. A new prognostic clinicopathological classification ofpituitary adenomas: a multicentric case-control study of 410 patients with 8years post-operative follow-up. Acta Neuropathol. 2013 Jul;126(1):123-35. doi: 10.1007/s00401-013-

1084-y. Epub 2013 Feb 12. PubMed PMID: 23400299.

75

Firth MA, Madera S, Beaulieu AM, Gasteiger G, Castillo EF, Schluns KS, et al. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med 2013;210:2981-90.

76

Fournier N, Toesca R, Bessereau J, Champenois A, Mazille A, Luigi S, Yvorra S, Paganelli F, Brun PM, Michelet P, Meyran D, Auffray JP, Bonello L. Ticagrelor or prasugrel for pre-hospital protocols

in STEMI ? Int J Cardiol. 2013 Oct 9;168(4):4566-7.

77 Franceschi F, By Y, Peyrouse E, Fromonot J, Gerolami V, Kipson N, Boussuges A, Brignole M, Fenouillet E, Deharo JC, Ruf J, Guieu R. A2A adenosine receptorfunction in patients with vasovagal syncope. Europace. 2013 Sep;15(9):1328-32. doi: 10.1093/europace/eut066. Epub

2013 Apr 17. PubMed PMID: 23594931.




















78 Frere C, Mercier-Bataille D, Suchon P, Aillaud MF. Le TCA, what else ? Spectra Biologie. 2013 Mar;

199 : 41-48

79

G. Hache. La fibromyalgie. Pharmacie clinique – Le Moniteur Hospitalier 2013 ; 259

80

Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, Barlier A, Morange I, Pacak K, Taïeb D. Functional characterization of nonmetastaticparaganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. Clin Endocrinol (Oxf). 2013 Aug;79(2):170-7. doi: 10.1111/cen.12126. Epub 2013May 6. PubMed PMID: 23230826; PubMed Central PMCID: PMC3610811.

81 Garand R, Beldjord K, Cavé H, Fossat C, Arnoux I, Asnafi V, Bertrand Y,Boulland ML, Brouzes C, Clappier E, Delabesse E, Fest T, Garnache-Ottou F, Huguet F, Jacob MC, Kuhlein E, Marty-Grès S, Plesa A, Robillard N, Roussel M, Tkaczuk J,Dombret H, Macintyre E, Ifrah N, Béné MC, Baruchel A. Flow cytometry and IG/TCRquantitative PCR for minimal residual disease quantitation in acute

lymphoblasticleukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia. 2013 ;27:370-6.

82 Gentile S, Beauger D, Speyer E, Jouve E, Dussol B, Jacquelinet C, Briancon S. Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France. Health Qual Life Outcomes 2013 May 30;11(1):88.

83

Goncalves TM, Alhanout K, Nicolay A, Dubus JC, de Santana DP, Andrieu V Comparative in vitro

performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler. J Aerosol Med Pulm Drug Deliv, 2013, 26(4): 223-7.

84

Gondouin B, Cerini C, Dou L, Sallée M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, Jourde- Chiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int. 2013 Oct;84(4):733-44.

85

Grados A, Ebbo M, Boucraut J, Vély F, Aucouturier P, Rigolet A, et al. Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease. Int J Rheumatol 2013;2013:426759.

86

Gravier G, Delliaux S, Ba A, Delpierre S, Guieu R, Jammes Y. Early ventilation-heart rate breakpoint during incremental cycling exercise. Int J Sports Med. 2014 Mar;35(3):191-8.

87

Gravier G, Delliaux S, Delpierre S, Guieu R, Jammes Y. Inter-individual differences in breathing pattern at high levels of incremental cycling exercise in healthy subjects. Respir Physiol Neurobiol. 2013 Oct 1;189(1):59-66. doi: 10.1016/j.resp.2013.06.027.

88 Gravier G, Steinberg JG, Lejeune PJ, Delliaux S, Guieu R, Jammes Y. Exercise-induced oxidative stress influences the motor control during maximal incremental cycling exercise in healthy

humans. Respir Physiol Neurobiol. 2013 May 1;186(3):265-72

89

Greliche N, Germain M, Lambert JC, Cohen W, Bertrand M, Dupuis AM, Letenneur L, Lathrop M, Amouyel P, Morange PE, Trégouët DA. A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis. BMC Med Genet. 2013;14:36 (IF = 2.536)

90 Grison S, Favé G, Maillot M, Manens L, Delissen O, Blanchardon E, Banzet N, Defoort C, Bott R, Dublineau I, Aigueperse J, Gourmelon P, Martin JC and Souidi M. Metabolomics identifies a biological response to chronic low-dose natural uranium contamination in urine samples. Metabolomics 2013;9:1168-1180 (IF = 4.505)

91 Grosdidier C, Quilici J, Loosveld M, Camoin L, Moro PJ, Saut N, Gaborit B, Pankert M, Cohen W, Lambert M, Beguin S, Morange PE, Bonnet JL, Alessi MC, Cuisset T. Effect of cyp2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications. Am J Cardiol. 2013;111:985-90 (IF = 3.425)








92 Gullett BK, Tabor D, Bertrand A, Touati A. Quality control for sampling of PCDD/PCDF emissions

from open combustion sources. Chemosphere. 2013 Sep;93(3):494-8.

93

Guy J, Antony-Debré I, Benayoun E, Arnoux I, Fossat C, Le Garff-Tavernier M, Raimbault A,

Imbert M, Maynadié M, Lacombe F, Béné MC, Wagner-Ballon O; GEIL(Groupe d'Etude Immunologique des Leucémies). Flow cytometry thresholds ofmyeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia. Br J Haematol. 2013 161:551-5.

94 Hajji H, Gérolami R, Solas C, Moreau J, Colson P. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents. 2013 Jun;41(6):595-7. doi: 10.1016/j.ijantimicag.2013.02.005.

95

Hourmant M, de Cornelissen F, Brunet P, Pavaday K, Assogba F, Couchoud C, Jacquelinet C; registre du REIN. Access to the waiting list and renal transplantation. Nephrol Ther. 2013 Sep;9 Suppl 1:S139-66.

96 Huber C, Wu S, Kim AS, Sigaudy S, Sarukhanov A, Serre V, Baujat G, Le Quan Sang KH, Rimoin DL, Cohn DH, Munnich A, Krakow D, Cormier-Daire. WDR34 mutations that cause short-rib polydactyly syndrome type III/severe asphyxiating thoracic dysplasia reveal a role for the NF-κB pathway in cilia. V.Am J Hum Genet. 2013 Nov 7;93(5):926-3

97 Imperiale A, Moussallieh FM, Sebag F, Brunaud L, Barlier A, Elbayed K, Bachellier P, Goichot B, Pacak K, Namer IJ, Taïeb D. A new specific succinate-glutamate metabolomic hallmark in sdhx- related paragangliomas. PLoSOne. 2013 Nov 27;8(11):e80539. doi: 10.1371/journal.pone.0080539. PubMed PMID: 24312232; PubMed Central PMCID: PMC3842321. J Thromb Haemost. 2013;1:111-21 (IF = 6.081)

98 Jaffrain-Rea ML, Rotondi S, Turchi A, Occhi G, Barlier A, Peverelli E, Rostomyan L, Defilles C, Angelini M, Oliva MA, Ceccato F, Maiorani O, Daly AF, Esposito V, Buttarelli F, Figarella-Branger D, Giangaspero F, Spada A, Scaroni C, Alesse E, Beckers A. Somatostatin analogues increase AIP expression insomatotropinomas, irrespective of Gsp mutations. Endocr Relat Cancer. 2013

Sep16;20(5):753-66. doi: 10.1530/ERC-12-0322. Print 2013 Oct. PubMed PMID: 23940012.

99 Jamilloux Y, Favier J, Pertuit M, Delage-Corre M, Lopez S, Teissier MP, Mathonnet M, Galinat S, Barlier A, Archambeaud F. A MEN1 syndrome with aparaganglioma. Eur J Hum Genet. 2013 Jun 19. doi: 10.1038/ejhg.2013.128. [Epubahead of print] PubMed PMID: 23778871.

100

Jammes Y, Steinberg JG, Olivier M, Brerro-Saby C, Condo J, Ravailhe S, Guieu R, Delliaux S. The mechanisms of the widespread production of phosphorylated HSP25 after fatiguing muscle stimulation. J Exp Biol. 2013 Oct 1;216(Pt 19):3620-6.

101 Jordan S, Ruzsics Z, Mitrovi? M, Baranek T, Arapovi? J, Krmpoti? A, et al. Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host Microbe 2013;13:535-45.

102

Jouanguy E, Gineau L, Cottineau J, Béziat V, Vivier E, Casanova JL. Inborn errors of the

development of human natural killer cells. Curr Opin Allergy Clin Immunol 2013;13:589-95.

103

Joulia F, Coulange M, Lemaitre F, Costalat G, Franceschi F, Gariboldi V, Nee L, Fromonot J, Bruzzese L, Gravier G, Kipson N, Jammes Y, Boussuges A, Brignole M, Deharo JC, Guieu R. Plasma adenosine release is associated with bradycardia and transient loss of consciousness during experimental breath-hold diving. Int J Cardiol. 2013 Oct 12;168(5):e138-41.

104

Jouve N, Despoix N, Espeli M, Gauthier L, Cypowyj S, Fallague K, et al. The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J Biol Chem 2013;288:2571-9.

















105 Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A,Deprez P, Lechêne P,

Grynberg A, Lairon D, Planells R, Gastaldi M. Beneficial effects of omega-3 fatty acids on the

consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr. 2013 ;52:1865-74. (IF = 3.84)

106

Kaspi E, Guillet B, Piercecchi-Marti MD, Alfaidy N, Bretelle F, Bertaud-Foucault A, Stalin J, Rambeloson L, Lacroix R, Blot-Chabaud M, Dignat-George F, Bardin N. Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development.

Angiogenesis. 2013 Apr;16(2):329-42.

107 Kerdiles Y, Ugolini S, Vivier E. T cell regulation of natural killer cells. J Exp Med 2013;210:1065-8.

108

Lacroix R, Desplat V, Dignat-George F et Sampol J. La leucémie lymphoïde chronique. Biochimie Hématologie. Le moniteur d'internat 2013

109

Lacroix R, Desplat V, Dignat-George F et Sampol J. Les lymphomes. Biochimie Hématologie.

110

Lacroix R, Desplat V, Dignat-George F et Sampol J. Les syndromes mononucléosiques. Biochimie

Hématologie. Le moniteur d'internat 2013

111

Lacroix R, Dignat-George F. Microparticles : new protagonists in pericellular and intravascular proteolysis. Seminars Thromb Haemost 2013 Feb; 39(1):33-9.

112 Lacroix R, Judicone C, Robert S, Arnaud L, Sabatier F and Dignat-George F. Chapter : Pre- analytical variables. Book : Exosomes and microvesicles in health and diseases. Standford Edition 2013

113

Lacroix R, Robert S, Sabatier F and Dignat-George F. Chapter : Flow cytometry. Book : Exosomes and microvesicles in health and diseases. Standford Edition 2013

114 Lacroix R, Sabatier F, Dignat-George F et Sampol J. La leucémie myéloïde chronique. Biochimie

Hématologie. Le moniteur d'internat 2013

115

Lacroix R., Dubois C., Leroyer A.S., Sabatier F., and Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost. 2013 Jun;11 Suppl 1:24-35.

116 Lacroix R., Judicone C., Mooberry M., Boucekine M., Key N.S. and Dignat-George F, on behalf of the ISH SSC Workshop. Standardization of the pre-analytical variables in plasma microparticles determination: results of the ISTH SSC Collaborative Workshop. J Thromb Haemost. 2013 Apr 2; 11(6): 1190-3.

117

Laine M, Doddo Siddo MN, Paganelli F, Dignat-George F, Bonello L. Improved biological efficacy of prasugrel one month after an acute coronary syndrome. Int J Cardiol. 2013 Sep 1;167(5):2329- 30.

118 Laine M, Paganelli F, Dignat-George F, Camoin-Jau L, Bonello L. Biological efficacy and clinical

safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot study.. Int J Cardiol. 2013 Apr 30;165(1):200-1.

119

Laine M, Toesca R, Berbis J, Frere C, Barnay P, Pansieri M, Peyre JP, Michelet P, Bessereau J, Camilleri E, Helaf O, Camaleonte M, Paganelli F, Dignat-George F, Bonello L. Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention. Thromb Res. 2013 Jul;132(1):e15-8

120

Laine M, Toesca R, Frere C, Paganelli F, Bonello L. Tailoring antiplatelet therapy--insanity orgood sense? Circ J. 2013;77(5):1150-1. Epub 2013 Mar 23.
















121 Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, et al. Factors associated

with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus

in the French general population. PLoS One 2013;8:e60127.

122

Laquérriere A, Maluenda J, Camus A, Fontenas L, Dieterich K, Nolent F, Zhou J, Monnier N, Latour P, Gentil D, Héron D, Desguerres I, Landrieu P, Beneteau C, Delaporte B, Bellesme C, Baumann C, Capri Y, Goldenberg A, Lyonnet S, Bonneau D, Estournet B, Quijano-Roy S, Francannet C, Odent

S, Saint-Frison MH, Sigaudy S, Figarella-Branger D, Gelot A, Mussini JM, Lacroix C, Drouin- Garraud V, Malinge MC, Attié-Bitach T, Bessieres B, Bonniere M, Encha-Razavi F, Beaufrère AM, Khung-Savatovsky S, Perez MJ, Vasiljevic A, Mercier S, Roume J, Trestard L, Saugier-Veber P, Cordier MP, Layet V, Legendre M, Vigouroux-Castera A, Lunardi J, Bayes M, Jouk PS, Rigonnot L, Granier M, Sternberg D, Warszawski J, Gut I, Gonzales M, Tawk M, Melki .Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.

J.Hum Mol Genet. 2013 Dec 20. Le moniteur d'internat 2013

123

Lecompte JF, Hery G, Potier A, Gorincour G, Giudicelli B, Philip N, Guys JM, de Lagausie P. Putative Criteria for Predicting Spontaneous Regression of Prenatally Diagnosed Thoracoabdominal

Cystic Lesions. Eur J Pediatr Surg. 2013 Sep 5. [Epub ahead of print] PubMed PMID: 24008545.

124 Lee SD, Calfee MW, Mickelsen L, Wolfe S, Griffin J, Clayton M, Griffin-Gatchalian N, Touati A. Evaluation of surface sampling for Bacillus spores using commercially available cleaning robots.

Environ Sci Technol. 2013 Mar 19;47(6):2595-601.

125

Loyens M, Thuny F, Grisoli D, Fournier PE, Casalta JP, Vitte J, et al. Link between endocarditis on porcine bioprosthetic valves and allergy to pork. Int J Cardiol 2013;167:600-2.

126 Magalon J, Billard-Daufresne LM, Gilbertas C, Hermanche E, Simon S, Lemarie C, Calmels B, Sabatier F, Gamerre M, Picard C, Chabannon C. Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.

Transfusion. 2013 Aug 14

127

Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F,

Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). Addiction. 2013 Jul;108(7):1250-8.

128

Massicot F., Hache G., David L., Chen D., Leuxe C., Garnier-Legrand L., Laprévote O., Coudoré F. P2x7 receptor activation and mitochondrial impairment in oxaliplatin-induced neuronal injury. Beneficial effects of anti-inflammatory or anti-oxidative drugs. PlosOne, 2013 June 27;8.

129 Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, et al. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood 2013;122:394- 404.

130

Maupetit-Méhouas S, Azzi S, Steunou V, Sakakini N, Silve C, Reynes C, Perezde Nanclares G, Keren B, Chantot S, Barlier A, Linglart A, Netchine I. Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patientswith GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Hum Mutat.

2013Aug;34(8):1172-80. doi: 10.1002/humu.22352. Epub 2013 May 28. PubMed PMID: 23649963.

131

Melenotte C, Rossi P, Reynaud Gaubert M, Harlé JR, Aissi K, Frances Y, et al. Une dyspnée et des phalanges raccourcies. Rev Med Interne 2013;34:785-6.

132

Michel J, Taïeb D, Jolibert M, Torrents J, Wassef M, Morange I, Essamet W, Barlier A, Dessi P, Fakhry N. Sinonasal paraganglioma with long-delayedrecurrence and metastases: genetic and

imaging findings. J Clin Endocrinol Metab. 2013 Nov;98(11):4262-6. doi: 10.1210/jc.2013-2320. Epub 2013 Sep 12. PubMed PMID: 24030938.
























133 Michot C, Corsini C, Sanlaville D, Baumann C, Toutain A, Philip N, Busa T, Holder M, Faivre L,

Odent S, Delrue MA, Till M, Jacquemont ML, Cordier MP, Goldenberg A, Sanchez E, Alix E, Poisson

S, Kayirangwa H, Lacombe D,Gilbert-Dussardier B, Pelet A, Roume J, Jacquette A, Isidor B, Giuliano F, Burglen L, Fradin M, Schaefer E, Alembick Y, Doray B, Moncla A, Héron D, Willems M,

Pinson L, Le Quan Sang KH, Le Merrer M, Cormier-Daire V, Sarda P, Amiel J, Lyonnet S, Geneviève D. Finger creases lend a hand in Kabuki syndrome. Eur J Med Genet. 2013 Oct;56(10):556-60. doi: 10.1016/j.ejmg.2013.07.005. Epub 2013 Aug 7. PubMed PMID: 23933090.

134

Milano G, Fanciullino R, Ciccolini J. Research highlights. Pharmacogenomics 07/2013; 14(9):1007- 9.

135

Million M, Walter G, Bardin N, Camoin L, Giorgi R, Bongrand P, et al. Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis 2013;57:57-64.

136

Mionnet C, Mondor I, Jorquera A, Loosveld M, Maurizio J, Arcangeli ML, Ruddle NH, Nowak J, Aurrand-Lions M, Luche H, Bajénoff M. Identification of a new stromal cell type involved in the

regulation of inflamed B cell follicles. PLoS Biol. 2013 ;11:e1001672.

137

Morange PE, Alessi MC.Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology. J Thromb Haemost. 2013;110-3 (IF = 6.081)

138 Morange PE, Trégouët DA.Current knowledge on the genetics of incident venous thrombosis.

139

Moro PJ, Quilici J, Giorgi R, Cuisset T, By Y, Boussuges A, Jammes Y, Bonnet JL, Ruf J, Fenouillet E, Guieu R. Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty. Int J Cardiol. 2013 Jun 5;166(1):225-9.

140

Narni-Mancinelli E, Ugolini S, Vivier E. Les cellules natural killer - Adaptation et mémoire dans le

système immunitaire inné Med Sci (Paris) 2013;29:389-95.

141

Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr Opin Immunol 2013;25:53-8.

142 Navarro C., De Sandre-Giovannoli A., Cantecor B., Roll P., Lévy N., Cau P. Ten years of translational research and valorisation in Progeria, from genetics to therapeutic applications and cosmetic. Médecine Sciences Amérique 2013;2(3):79-93.

143

Navarro CL., Esteves-Vieira V., Courrier S., Boyer A., Nguyen TD., Huong LTT., Meinke P., Schröder W., Cormier-Daire V., Sznajer Y., Amor D., Lagerstedt K., Biervliet M., van den Akker P., Cau P., Roll P., Lévy N., Badens C., Wehnert M., De Sandre-Giovannoli A. ZMPSTE24 (FACE1)

mutations in patients affected with Restrictive Dermopathy and related progeroid syndromes. European Journal of Human Genetics 2013 Epub Oct 30.

144 Nee L, Franceschi F, Resseguier N, Gravier G, Giorgi R, Gariboldi V, Collart F, Michelet P, Deharo

JC, Guieu R, Kerbaul F. High endogenous adenosine plasma concentration is associated with atrial fibrillation during cardiac surgery with cardiopulmonary bypass. Int J Cardiol. 2013 Apr

30;165(1):201-4. doi: 10.1016/j.ijcard.2012.08.018. Epub 2012 Sep 29. PubMed PMID: 23026311.

145 Nee L, Giorgi R, Garibaldi V, Bruzzese L, Blayac D, Fromonot J, Kipson N, Bellezza M, Lejeune PJ, Guieu R, Kerbaul F. Ischemia-modified albumin and adenosine plasma concentrations are

associated with severe systemic inflammatory response syndrome after cardiopulmonary bypass. J Crit Care. 2013 Oct;28(5):747-55. doi: 10.1016/j.jcrc.2013.02.014.












146 Nogueira JP, Maraninchi M, Lorec AM, Samuelian-Massat C, Begu-Le Corroller A, Nicolay A,

Gaudart J, Portugal H, Vialettes B, Valéro R.Growth hormone level at admission and its evolution

during refeeding is predictive of short term outcome in restrictive anorexia nervosa. Brit J Nutr, 2013, 109(12): 2175-81.

147

Nogueira JP, Valéro R, Maraninchi M, Lorec AM, Samuelian-Massat C, Bégu-Le Corroller A, Nicolay A, Gaudart J, Portugal H, Vialettes B. Growth hormone level at admission and its evolution during refeeding is predictive of short term outcome in restrictive anorexia nervosa. Brit J

Nutr.2013;109:2175-8 (IF = 3.342

148

Noris P, Favier R, Alessi MC, Geddis AE, Kunishima S, Heller PG, Giordano P, Niederhoffer KY, Bussel JB, Podda GM, Vianelli N, Kersseboom R, Pecci A, Gnan C, Marconi C, Auvrignon A, Cohen

W, Yu JC, Iguchi A, Miller Imahiyerobo A, Boehlen F, Ghalloussi D, De Rocco D, Magini P, Civaschi E, Biino G, Seri M, Savoia A, Balduini CL. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122:1987-9. (IF = 9.060)

149

Oulidi A, Bokhobza A, Gkika D, Vanden Abeele F, Lehen'kyi V, Ouafik L, Mauroy B, Prevarskaya N. TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion,

migration and invasion. PLoS One. 2013;8(5):e64885.

150

Pankert M, Quilici J, Loundou AD, Verdier V, Lambert M, Deharo P, Bonnet G, Gaborit B, Morange PE, Valéro R, Dutour A, Bonnet JL, Alessi MC, Cuisset T. Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting. Am J Cardiol. 2014;113(1):54-9. (IF = 3.425)

151

Pankert M, Quilici J, Loundou AD, Verdier V, Lambert M, Deharo P, Bonnet G, Gaborit B, Morange PE, Valéro R, Dutour A, Bonnet JL, Alessi MC, Cuisset T. Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting. Am J Cardiol. 2014; 1;113:54-9. (IF = 3.425)

152

Pellegrini L, Bennis Y, Guillet B, Velly L, Bruder N, Pisano P. Cell therapy for stroke: from myth to reality. Rev Neurol (Paris). 2013 Apr ; 169(4):291-306

153

Pellegrini L., Bennis Y., Guillet B., Velly L, Sabatier F, Dignat-George F, Nicolas Bruder, Pisano.P. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischaemia in rats. Neurol Res 2013 Nov,35(9):937-47

154

Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bébéar C. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect. 2013 Apr;19(4):E212-7.

155

Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Gjelstad IM, Gibney J, Kieć-Wilk B, Camargo A, Helal O, Karlström B, Blaak EE, Hall W, Risérus U, Dembińska-Kieć A, Defoort C, Saris WH, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J. Gene-nutrient interactions on the phosphoenolpyruvatecarboxykinase influence insulin sensitivity in metabolic syndrome subjects. Clin Nutr. 2013;32:630-5 (IF = 3.731)

156

Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C, Kaspi E, Robaglia-Schlupp A, Tamalet CN, Lévy N, Poizot-Martin I, Cau P, Roll P. Correction: HIV

Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 "Aging" Study. PLoS One. 2013 Aug 14;8(8).

157 Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-

1672]. Mult Scler 2013;19:831-2.

158

Peters GJ, Honeywell RJ, Maulandi M, Giovannetti E, Losekoot N, Etienne-Grimaldi MC, Milano G, Serdjebi C, Ciccolini J; EORTC-Pharmacology and Molecular Mechanism Group. Selection of the best blood compartment to measure cytidine deaminase activity to stratify for optimal gemcitabine or cytarabine treatment. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):403- 12.









159 Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, Kiec-

Klimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche

HM. Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype.Obesity. 2013;1:e154-61 (IF = 4.389)

160

Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, Kiec-Klimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche HM. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk

metabotype. Obesity (Silver Spring). 2013;21: E154-61 (IF = 4.389)

161 Plaisancié J, Bailleul-Forestier I, Gaston V, Vaysse F, Lacombe D, Holder-Espinasse M, Abramowicz M, Coubes C, Plessis G, Faivre L, Demeer B, Vincent-Delorme C, Dollfus H, Sigaudy S, Guillén- Navarro E, Verloes A, Jonveaux P, Martin-Coignard D, Colin E, Bieth E, Calvas P, Chassaing. Mutations in WNT10A are frequently involved in oligodontia associated with minor signs of

ectodermal dysplasia. N.Am J Med Genet A. 2013 Apr;161A(4):671-8.

162

Plantier S, Harlé JR, Gautier M, Bertin D, Granel B, Sarles J, et al. Dépistage et suivi immunologique de la maladie c?liaque : expérience du CHU de Marseille. Rev Med Interne

2013;34:735-40.

163

Poggi M, Kara I, Brunel JM, Landrier JF, Govers R, Bonardo B, Fluhrer R, Haass C, Alessi MC, Peiretti F. Palmitoylation of TNF alpha is involved in the regulation of TNF receptor 1 signaling. Biochimica et Biophisica Acta Mol Cell Res. 2013;1833:602-12 (IF = 5.538)

164

Poizot-Martin I, Faucher O, Obry-Roguet V, Nicolino-Brunet C, Ronot-Brégigeon S, Dignat-George F, Tamalet C. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years. J Clin Virol. 2013 Aug;57(1):351-5

165

Poizot-Martin I, Solas C, Allemand J, Obry-Roguet V, Pradel V, Bregigeon S, Faucher O, Lacarelle B. Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir trough concentration. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):375-80.

166 Poli A, Kmiecik J, Domingues O, Hentges F, Bléry M, Chekenya M, et al. NK cells in central nervous system disorders. J Immunol 2013;190:5355-62.

167

Popovici C, Busa T, Missirian C, Milh M, Moncla A, Philip N. Mosaic 15q13.3 deletion including CHRNA7 gene in monozygotic twins. Eur J Med Genet. 2013 May;56(5):274-7. doi: 10.1016/j.ejmg.2013.02.005. Epub 2013 Feb 27. PubMed PMID: 23454271.

168

Pradeu T, Jaeger S, Vivier E. The speed of change: towards a discontinuity theory of immunity? Nat Rev Immunol 2013;13:764-9.

169

Prugger C, Luc G, Haas B, Morange PE, Ferrieres J, Amouyel P, Kee F, Ducimetiere P, Empana JP; PRIME Study Group. Multiple biomarkers for the prediction of ischemic stroke: the PRIME study.ArteriosclerThromb Vasc Biol. 2013;33:659-66 (IF = 6.338)

170

Quilici J, Fugon L, Beguin S, Morange PE, Bonnet JL, Alessi MC, Carrieri P, Cuisset T. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. Int J Cardiol. 2013;168(1):568-9 (IF = 6.802)

171

Quilici J, Fugon L, Beguin S, Morange PE, Bonnet JL, Alessi MC, Carrieri P, Cuisset T. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. Int J Cardiol. 2013;168:568-9. (IF = 5.509)

172

Regaya I, Aidi-Knani S, By Y, Condo J, Gerolami V, Berge-Lefranc JL, Ben Hamida J, Sabatier JM, Fenouillet E, Guieu R, Ruf J. SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells. Biores Open Access. 2013 Apr;2(2):163-8.

173

Regaya I, Aidi-Knani S, By Y, Condo J, Gerolami V, Berge-Lefranc JL, BenHamida J, Sabatier JM, Fenouillet E, Guieu R, Ruf J. SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells. Biores Open Access. 2013 Apr;2(2):163-8. doi: 10.1089/biores.2012.0282. PubMedPMID: 23593569; PubMed Central PMCID: PMC3620471.
































174 Robert P, Touchard D, Bongrand P, Pierres A. Biophysical description of multiple events

contributing blood leukocyte arrest on endothelium. Front Immunol 2013;4:108.

175

Rodien P, Barlier A. [French Society of Endocrinology, Paris 2013]. AnnEndocrinol (Paris). 2013 Sep;74(4):235. doi: 10.1016/j.ando.2013.07.002. Epub2013 Aug 20. French. PubMed PMID: 23972380.

176 Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med 2013;5:195ra96.

177

Sabater-Lleal M, Huang J, Chasman DI, Naitza S, Dehghan A, Johnson AD, Teumer A, Reiner AP, Folkersen L, Basu S, Rudnicka AR, Trompet S, Mälarstig A, Baumert J, Bis JC, Guo X, Hottenga JJ, Shin SY, Lopez LM, Lahti J, Tanaka T, Yanek LR, Oudot-Mellakh T, Wilson JF, Navarro P, Huffman JE, Zemunik T, Redline S, Mehra R, Pulanic D, Rudan I, Wright AF, Kolcic I, Polasek O, Wild SH,

Campbell H, Curb JD, Wallace R, Liu S, Eaton CB, Becker DM, Becker LC, Bandinelli S, Räikkönen K, Widen E, Palotie A, Fornage M, Green D, Gross M, Davies G, Harris SE, Liewald DC, Starr JM,

Williams FM, Grant PJ, Spector TD, Strawbridge RJ, Silveira A, Sennblad B, Rivadeneira F, Uitterlinden AG, Franco OH, Hofman A, van Dongen J, Willemsen G, Boomsma DI, Yao J, Jenny NS, Haritunians T, McKnight B, Lumley T, Taylor KD, Rotter JI, Psaty BM, Peters A, Gieger C, Illig T, Grotevendt A, Homuth G, Völzke H, Kocher T, Goel A, Franzosi MG, Seedorf U, Clarke R, Steri M, Tarasov KV, Sanna S, Schlessinger D, Stott DJ, Sattar N, Buckley BM, Rumley A, Lowe GD,

McArdle WL, Chen MH, Tofler GH, Song J, Boerwinkle E, Folsom AR, Rose LM, Franco-Cereceda A, Teichert M, Ikram MA, Mosley TH, Bevan S, Dichgans M, Rothwell PM, Sudlow CL, Hopewell JC, Chambers JC, Saleheen D, Kooner JS, Danesh J, Nelson CP, Erdmann J, Reilly MP, Kathiresan S, Schunkert H, Morange PE, Ferrucci L, Eriksson JG, Jacobs D, Deary IJ, Soranzo N, Witteman JC, de Geus EJ, Tracy RP, Hayward C, Koenig W, Cucca F, Jukema JW, Eriksson P, Seshadri S, Markus HS, Watkins H, Samani NJ, Wallaschofski H, Smith NL, Trégouët D, Ridker P, Tang W, Strachan

DP, Hamsten A, O'Donnell CJ. Multi-Ethnic Meta-Analysis of Genome-Wide Association Studies in Over 100,000 Subjects Identifies 23 Fibrinogen-Associated Loci but no Strong Evidence of a Causal Association between Circulating Fibrinogen and Cardiovascular Disease. Circulation. 2013 17;128:1310-24. (IF = 15.202)

178 Sallee M, Fontes M, Louis L, Cerini C, Brunet P, Burtey S. Alternative Splicing Events Is Not a Key

Event for Gene Expression Regulation in Uremia. PLoS One. 2013 Dec 16;8(12):e82702

179

Sallée M, Fontès M, Louis L, Cérini C, Brunet P, Burtey S. Alternative splicing events is not a key event for gene expression regulation in uremia. PLoS One. 2013;8:e82702. (IF = 3.730)

180

Salort-Campana E1, Nguyen K, Lévy N, Pouget J, Attarian S.Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012.Rev Neurol (Paris). 2013 Aug-Sep;169(8- 9):573-82.

181 Sanchez R, Picard N, Mouly-Bandini A, Chalvignac V, Lacarelle B, Sampol-Manos E. Severe decrease of cyclosporine levels in a heart transplant recipient receiving the direct thrombin inhibitor argatroban. Ther Drug Monit. 2014 Jun;36(3):273-7.

182 Sarlon-Bartoli G., Bennis Y., Lacroix R., Piercecchi-Marti MD., Bartoli MA., Arnaud L., Boudes

A., Sarlon E., Thevenin B., Leroyer AS., Squarcioni C., Magnan PE., Dignat-George F. and Sabatier F. Plasmatic levels of leukocyte-derived microparticles predict unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol. 2013 Oct 15;62(16):1436-41.

183 Saveanu A, Sebag F, Guillet B, Archange C, Essamet W, Barlier A, Palazzo FF, Taïeb D. Targeting Dopamine Receptors Subtype 2 (D2DR) in Pheochromocytomas: Head-to-Head Comparison Between In Vitro and In Vivo Findings. J Clin Endocrinol Metab. 2013 Dec;98(12):E1951-5. doi: 10.1210/jc.2013-2269. Epub 2013 Sep 5. PubMed PMID: 24009136.

184

Scodavolpe S, Quaranta S, Lacarelle B, Solas C. Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization. Ann Biol Clin (Paris). 2014 Aug 1;72(4):391-404





























185 Serdjebi C, Ciccolini J, Fina F, Delarue A, Verschuur A, Lacarelle B, Ouafik L, André N.

Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver

transplant: A deadly gift? Pharmacogenet Genomics. 2014 Jul 7. [Epub ahead of print]

186

Serdjebi C, Seitz JF, Ciccolini J, Duluc M, Norguet E, Fina F, Lacarelle B, Ouafik L, Dahan L. Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen. Pharmacogenomics. 2013 Jul;14(9):1047-51. doi:

10.2217/pgs.13.93.

187

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol 2013;13:145-9.

188

Stalin J, Harhouri K, Hubert L, Subrini C, Lafitte D, Lissitzky JC, et al. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin. J Biol Chem 2013;288:8991-9000.

189

Stepanian A, Bourguignat L, Henou S, Coupaye M, Samomon L, Alessi MC, Msika S, De Prost D.

Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity. 2013;2236-43 (IF = 4.389)

190

Stephan D, Sbai O, Wen J, Couraud PO, Putterman C, Khrestchatisky M, et al. TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation 2013;10:9.

191 Taïeb D, Yang C, Delenne B, Zhuang Z, Barlier A, Sebag F, Pacak K. Firstreport of bilateral pheochromocytoma in the clinical spectrum of HIF2A-relatedpolycythemia-paraganglioma

syndrome. J Clin Endocrinol Metab. 2013May;98(5):E908-13. doi: 10.1210/jc.2013-1217. Epub 2013 Mar 28. PubMed PMID: 23539726; PubMed Central PMCID: PMC3644612.

192 Tang W, Teichert M, Chasman DI, Heit JA, Morange PE, Li G, Pankratz N, Leebeek FW, Paré G, de Andrade M, Tzourio C, Psaty BM, Basu S, Ruiter R, Rose L, Armasu SM, Lumley T, Heckbert SR, Uitterlinden AG, Lathrop M, Rice KM, Cushman M, Hofman A, Lambert JC, Glazer NL, Pankow JS,

Witteman JC, Amouyel P, Bis JC, Bovill EG, Kong X, Tracy RP, Boerwinkle E, Rotter JI, Trégouët DA, Loth DW, Stricker BH, Ridker PM, Folsom AR, Smith NL.A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.Genet Epidemiol. 2013;37:512-21 (IF = 4.015)

193 Textoris J, Ivorra D, Ben Amara A, Sabatier F, Ménard JP, Heckenroth H, Bretelle F, Mege JL. Evaluation of Current and New Biomarkers in Severe Preeclampsia : A Microarray Approach

Reveals theVSIG4 Gene as a Potential Blood Biomarker. PLoS One. 2013 Dec 9;8(12):e82638

194 Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre

O, Castermans E, Beckers A, RuszniewskiP, Le Bras M, Delemer B, Bouchard P, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P. Higher risk of death among MEN1 patients withmutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE)

cohort study. Hum Mol Genet. 2013 May 15;22(10):1940-8. doi10.1093/hmg/ddt039. Epub 2013

Jan 31. PubMed PMID: 23376981.

195 Tran Mau-Them F, Willems M, Albrecht B, Sanchez E, Puechberty J, Endele S, Schneider A, Ruiz Pallares N, Missirian C, Rivier F, Girard M, Holder M, Manouvrier S, Touitou I, Lefort G, Sarda P, Moncla A, Drunat S, Wieczorek D, Genevieve D. Expanding the phenotype of IQSEC2 mutations:

truncating mutations in severe intellectual disability. Eur J Hum Genet. 2013 May 15.

196

Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342:971-6.





















197 Visentin S, Baudesson de Chanville A, Loosveld M, Chambost H, Barlogis V.[Infantile visceral

leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome]. Arch

Pediatr. 2013 ;20:1225-9.

198 Vitte J, Bongrand P. Serum tryptase determination in patients with acute allergic reactions. J Allergy Clin Immunol 2013;131:1714.

199 Vivier E, Ugolini S, Nunès JA. ADAPted secretion of cytokines in NK cells. Nat Immunol 2013;14:1108-10.

200 Vors C, Pineau G, Gabert L, Drai J, Louche-Pélissier C, Defoort C, Lairon D, Désage M, Danthine S,

Lambert-Porcheron S, Vidal H, Laville M, Michalski MC. Modulating absorption and postprandial handling of dietary fatty acids by structuring fat in the meal: a randomized crossover clinical trial. Am J ClinNutr. 2013;97:23-36 (IF = 6.669)

201 Wood JP, Calfee MW, Clayton M, Griffin-Gatchalian N, Touati A, Egler K. Evaluation of peracetic

acid fog for the inactivation of Bacillus anthracis spore surrogates in a large decontamination

chamber. J Hazard Mater. 2013 Apr 15;250-251:61-7.

CONTRATS ANNÉE 2013 S. ATTARIAN – « Outils pour l’évaluation thérapeutique dans la maladie de Charcot-Marie-Tooth de type IA : critères de jugement et biomarqueurs » - AP-HM – PHRC Inter régional 2013

P. ROLL : « Matrice nucléaire et Cancers : analyses génomique par puces à ADN et protéique des cellules obtenues par ponction pleurale », ARARD (2009-2013)

P. ROLL : « Microparticules, vecteurs d’information génétique au cours de l’infection par le VIH ? », Projet de recherche ANRS (2012-2013)

L. NEE : Effets de la caféine dans le FA post opératoire – AORC-

A. HAUTIER « RECHERCHE DE BIOMARQUEURS INNOVANTS : EXPRESSION DE HIF-1α ET DE SES ISOFORMES DANS LE SANG ET LES TISSUS CUTANES DES GRANDS BRULES » - AORC - Investigateurs associés : Amin BEN LASSOUED et Pr Jean GABERT. Références CPP : 2012-23 / Référence du Comité : 12 49 / Numéro d'identification : 2012-A00644

A. BARLIER/ A. SAVEANU/ A. ENJALBERT : Nouveaux déterminants moléculaires des déficits hypophysaires - ANR 2008-2013

V. GEROLAMI : Essai thérapeutique TICAGRELOR 2012-2013

V. GEROLAMI : Hémochromatose de type 4 - Ministère santé PHRC -2010-2013

A. BARLIER . H. ZATTARA : Séquencage du gène VHL dans les hémangioblastomes, impact psychologique lors de la reconvocation des patients - AORC 2013 - 2013-2014

N. LEVY: Neuromics - CEE FP7-305121 -Nov 2012

N. LEVY: MNH-DECRYPT : Genomics, pathophysiology and therapeutic approaches in a panel of rare genetics diseases mainly affecting muscle, heart and nervous system – AFM- Juin 2010










J. CICCOLINI - « Pharmacocinétique du bévacizumab » Subvention Cancéropôle 2013 J. CICCOLINI - Recherche des effets séquernces anti-angiogéniques/cytotoxiques » Contrat Roche 2013

J. CICCOLINI - « Développement des ANC »Subvention Gefluc 2013

C. DUBOIS -« Rôles des microparticules dans l’initiation et la régulation des processus de thromboses et de métastases » MiniRev – ANR -2009 2013

C. DUBOIS -« Rôle des plaquettes sanguines dans le développement d’une tumeur et la formation de métastases dans un modèle murin du cancer du pancréas » - ARC-2012 2013

U. SIMEONI F. SABATIER - « Encéphalopathie anoxo-ischémique néonatale : étude de la tolérance et de la faisabilité d’un traitement curatif par les cellules souches du sang du cordon ombilical »- PHRC- 2010 2013

B.GRANEL N. BARDIN - « Sclérodermie et marqueurs vasculaires » - AORC Sénior- 2013

J.R. HARLE F. DIGNAT-GEORGE - « Etude de la lésion endothéliale dans la Drépanocytose »- AORC Sénior – 2011 2013

P. PAUL - « Evaluation de la réaction humorale et cellulaire anti-endothéliale dans la survenue du rejet de greffe cardiaque » - AAP 2010 Recherche Clinique Translationnelle -2010 2013

F. DIGNAT-GEORGE - « CD 146 nouvelle cible dans les pathologies vasculaires » -FONDATION DE FRANCE – 2012 2014

C.DUBOIS - « Etude du pouvoir antitumoral du Clopidrogrel dans un modèle murin du cancer du pancréas » - FORMATION RECHERCHE TRANSLATIONNELLE EN CANCEROLOGIE-2009 2013

C.DUBOIS - « Study of the antitumoral effect of Clopidogrel in a mouse model of pancreatic cancer » -

GFTC – 2012 2013 F. DIGNAT-GEORGE - Exploratory assessment of biomarkers in female patients suffering from chronic venous leg ulcer versus control subjects free of leg ulcer - Laboratoire SERVIER- 2013

M.CANAULT /M.C.ALESSI - Bases cellulaires et moléculaires du risque thrombotique dans l'insulino résistance : étude dans la plaquette - Fondation de France – 2012 2013

M.C. ALESSI - Rôle de la molécule de costimulation CD28 dans le développement de l'état inflammatoire et de la résistance à l'insuline associés à l'obésité - Société Fancophone de Diabète- 2012 2013

M.C. ALESSI - Subvention Annuelle – FRM- 2013

BREVETS ANNÉE 2013

Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog based-chemotherapy. Inventeurs : Ciccolini, Mercier, Dahan, Iliadis, Seitz, Ouafik. N° dépôt : US 20130011392 A1. Année de dépôt :2009. Année de publication : 10 janvier 2013. Déposant AMU, co- déposant : AP-HM.

Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog based-chemotherapy Brevet - États-Unis US 20130011392 A1 Publié le 10 janvier 2013

Développement d’un système de lecture automatisé. Bertin D, Bongrand P, Bardin N. European patent n°

1000191432. 2013. AP-HM.



THESES DE DOCTORAT ANNÉE 2013

Mathey-Turba Camille –« « JAK2 et syndromes myeloproliferatifs : comparaison de méthodes diagnostiques » - 18 janvier 2013.

Franceschi Frédéric « Contribution à l’étude du système adénosinergique en pathologie cardiovasculaire » - 22 Février 2013

Bennis Youssef . L'érythropoïétine, agent d'optimisation de la thérapie cellulaire par progéniteurs endothéliaux dans l'AVC ischémique et l'ischémie aigüe des membres inférieurs. Mars 2013

Taulelle Jean-Marie – « Quantification de la mutation JAK2 V617 F : Que faire des patients faiblement positifs ? Etude de 165 patients JAK2 V617F positifs entre 2008 et 2010 à l’AP-HM » - 21 juin 2013.

Bonello Nathalie. Conséquences des laminopathies dans l’endothélium vasculaire. Septembre 2013

Favier Marie. Pathologies plaquettaires héréditaires : caractérisation d’une nouvelle mutation. Septembre

2013 Gravier Gilles « Cinétique des réponses cardiorespiratoires et métaboliques lors d’un exercice incrémentiel maximal chez l’homme » – 18 novembre 2013.

Gondouin Bertrand. Les toxines urémiques provoquent un phénotype procoagulant de l’endothélium par la voie du facteur de transcription AHR. Novembre 2013

Darbousset Roxane. Rôle des polynucléaires neutrophiles dans la formation d'un thrombus in vivo dans un

modèle murin après blessure au rayon laser. Décembre 2013 Amira Mohamed. Nouvelles molécules thérapeutiques en développement pour les Tumeurs Neuroendocrines d’origine gastroentéropancréatiques et hypophysaires: Preuves de concept in vitro dec

2013

http://www.worldcat.org/search?q=au%3AMathey-Turba%2C%2BCamilla&qt=hot_author

Documents

POLE HOSPITALIER BIOLOGIE - medecine.univ-amu.fr · Pôle hospitalier. Biologie 2/21 Mise à jour : janvier 2015 Alain Nicolay (MCU-PH) Marguerite Gastaldi (MCU-PH) Catherine Defoort